Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Editorial: Spoilt? Pharma? Surely Some Mistake

This article was originally published in Scrip

Executive Summary

Some people reckon that what others say of us is none of our business. It's a useful maxim for retaining sanity in the Twitter and Google age, but perhaps there are times when a bit of constructive criticism is good for the soul. We all know that the public perception of the pharma industry isn't great, but the opinions of an Ivy League economics professor laid out in a recent JAMA Forum commentary may sting. Paraphrasing, it seems Professor Uwe Reinhardt thinks you're a bit spoilt: fragile little birds shielded by government from the harsh realities of the free market, and enjoying monopoly positions. He's got a point.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts